July 30 (Reuters) - SciVac Therapeutics Inc VAC.TO :
* Following discussions with israeli ministry of health recalling from market
all sci-b-vac sold by from January 1, 2012 to present
* Says company is diligently investigating the failure that resulted in the
damaged vials
* Says recall primarily affects the israeli and Hong Kong markets
* There have been no reports of harm to any patients, nor have there been any
reports with respect to sci-b-vac's efficacy or safety
* After inspection,determined that some unshipped packages of sci-b-vac
hepatitis b vaccine contained small number of damaged vials
* Israeli ministry of health informed co it may continue manufacturing
sci-b-Vac(TM) uninterrupted
* Scivac therapeutics-co may continue manufacturing sci-b-vac so long as co
uses alternative labeling process until issue can be appropriately remedied
* Source text for Eikon ID:nMKWfvsrCa
* Further company coverage VAC.TO